ࡱ> Root EntrypuA!@,FileHeaderaDocInfo[HwpSummaryInformation.S "#$%&'()*+,/.0-1234567Root EntrypuA!@,FileHeaderaDocInfo[HwpSummaryInformation.S "#$GIF89aɻxxxkkk]]]PPPCCC555((( d`LH00`Hذ̘`H0|pdXL@`0H `H0`dHL`H0xp`XH@0d LȰ``HH00dLؘȀ`H0xp`XH@d0L `H0d`LH`H0|pdXL@0`$H`dHL00`HذȘdL0xp`XH@0` HdH0ȳ``HHdL0xp`XH@`0H Ը̰ĠऀؘpȈXxHp@h@d8`8X0xT0pH dxddxd`d`p`|``x`p``x`!, H*\ȰÇ#JHŋ3jȱǏ CIɓ(S\ɲ˗0cʜI͛8sɳϟ@ JѣH*]ʴӧPJJիXjʵׯ`ÊKYv`ZgoU\mҤ__xK_+^xǐ#KLyaf~ylv em,u^ԀQq|wulpl߮ &uȓ۞wGޭWx`a>`{Sk}ϿPg H|q[ Xk7vgZ]=jA(އG:uF4цp"vc0VhT"yV͹Uڄ I\`6&ȢE+RNBOc)j饋:`q7x額Fw^>)[ Jy#h)7F%F;ޙ"aYh.btQ#DV]f^xvR?)џbpVz %bbiޝIwJm.ОTE.R*Tafcw+BfmzAڤ۱PzK6(i;>ZsE9=vi+ K8)h Ih\:q#wXl/=Hr 3ona[mBf˫q0[tljJ-ȆK!{n0!SKG̳DI I([zrÌ-nw-N1=VܯMnor-mkqss_{yn xy5h+K8AI&Y2}1Z^Ӂ7{K:Mt;8{.ևӎi ϊi/Kǻߧo_m7cs9=mZְ5%(qÖƆ+QPFUw!@:z=v.;ݕ6sykL5 lvJ_)0s8 8B|3F1 O(i35=OShz`e sJq@b]L >Vg Aqt !@,*"Vwe 6ȕ \Z81/c$hR1ɓ0:j$û2\K'=]=L RYR)Ǭe&O H .xh? 87vś}$+O\F>Xb[4bnx=rr'+՘K MEv yfsA]iO3,G9Βa&E*R##ըu&It*ŤBW (5'HW)3BD$RbI% PjJlKꟘSnYi,eDF ZqղdTO/WE|!nuplԼ`LGi0UN &0K];ץ,\>GrԴ`DaY,~qQڈ4瓪nw{RtlKEU(Šƌ wÏõUbM*Uzwӝ$Sj&65 yXVG l8|0sI)mIl\Srm~$1_bVh={Ֆ-.zQ(j +)lѶ qJ^,+1HQUP xb1SU?ln/n酩0z5Un(nU1ޛ9=Xf9u籫ǔ.|`EyOf{^j$k/*_-S{>~GV\-HWP Document FileۤjiT9)~/kO:ʨMjdu(7qMYD8N;9ohۯ֒e+9,*ұ%98G/fQtgإ:*tϿ#m# y S ? ;WC{cg~b.ϔdN$J2udILw$].;wG 1j=D}kQǿ26i  R[QQxSLLQ$ 1x xA!K੆ x(ͶI:dw̛6=-4k.mL#'q-T0僐D;Îp;Î$رv HJr4v<lI)a'G1$]^Po)* )嚍ŵEgY-BOR:m%_2,6N^2.=|$\`%dGI_NLl;; bEU_uu ɏr< \cx{QzjR~c’,vVj̖3cNÑp8~98Jw}Us}̔(ûss,+ ~C[vqybrQ)FxĿ%K i޳jM)6u@DO 6C,H,#GB!k0~ 6*7=M*Z:ҙ#?*?ӿT@Y~X+mj3'm[v|:j)%C$Mϼ5#cd߈an carcinoma model. Thus, simultaneous blockade of VEGF-A and angiopoietins with DAAP is an effective therapeutic strategy for blocking tumor angiogenesis, metastasis, and vascular leakage. Recently, based on Korean medicine literatures, 'Dong-eui-bo-gam (ٳ>V=lE~s# %0FCE\ڎ )@^rwk]dD"EHH %(i)(T)'wwo}{uQ"Ds2M\?2B7O|ǫa:r[f79He@lO|)y3P h As1?MtAs %W[ڿY8n1 w#~ K5dYPX9$sQʒU71Lv'ÔhXyiKΙyf;Zg˷/>##|/cou*}q&[ ' W5SDwY,YQR)RL9]{{cۜjZdٴcl7ucTR2 A_T и4B Ў:t"r)6[b4*Fu/kh+Wٿ^>֊P}eثZ.»Q[ ?*GDM iX]/e?5KiBP:@UinB?U>kabFIGY>ْf5Kg:+ZEzEGPOVtkZ׬_*^\j~U]T *139BQT$/шȊ*V$Myd.#H(*9៩ f2^܅>jʫZ[^S+^ ,}Q{+xFmu[]2UGmYD~ʘאy7U^TN96՛DTf %rJеw =ZJ2$azȅORT&osZZ%)0sAvPc$?.tTY驟A~SԛʖI8@|w?F6&;C?ʭs >$??mmo2AOR&԰9!>,(s5]}67c76k8+DjzߢwHJ+9>l NCWbTpIږT;aL4/J4L%*y}*}*ⷎήܻ(9gt!+$|E]䤌5qXMt9BŊ13.;cS[CܖJXr=cIjx ZW~Uۧ(_zlo3>WMhA~/5j[K,TZ I!ֈB=TT"(E؋bzAqCv 9Dx(7dwMv_7o&^r7;@y2b}lL'pE0ƼE̿lb٘3[1w1=0gc~bl1bfcc?1ac`M6&Xq 憷CHr@}#{d E#3 f;;}y<}t~^5kklQ(*h^G䜖c˩rU!DĄØv8J&J+Q3h?C\]4;$1gF& 0W9pթBs җ3V!m:]N4Onm}tb8YP/#E,fuؚ=F T`:.s1E2 I](@.a(Y<__z='o䫒:C\7,Sn6N6 Zsb#JޚA59 Lm;W̛"#9_Yqc@KeU<Z4PR^\JyYP ˋr`F|~D$Am\\,FLUN*θgvu8eRO^- 01bg/?'?f;ZJRu1]@LH\XbcK -*nOpB!1bmmY!$&p?gfNK{Fm37s|gc>4?@ABCDEFGHIJKLMNOPQRTUVWXYZ\]^_`ebcdfghijklmnopqstwxyz{|}~BodyText p"نApنAPrvImage PrvTextDocOptions puApuASection0H _x0_7ŕya}ټagc^@Q\=i#s8# =n<<8:}N t"<4tJ*٘J9$YYh}оlRRѼLV%dbYqr3V>Js p#sr`G<-}<$iZ(?s15klփ^{9[jUֺ Zzly9.;`(;˩MVwXeYgkQ8[VD}fu&m ,cQJ5([>?@ABCDEFGHIJKLMNOPQRTUVWXYZ\]^_`ebcdfghijklmnopqstwxyz{|}~Scripts puApuAJScriptVersion u DefaultJScriptr_LinkDocv 8] <\><New Discoveries from natural compounds> <\Դ><A variety of anti-angiogenic agents, including Avastin, are on the market. Recently, there have been some drugs which inhibit double or multiple angiogenic factors rather than inhibit single angiogenic factors. We have developed a double antiangiogenic protein, DAAP, which targets VEGF and angiopoietins, and has been developed to inhibit cancer angiogenesis, metastasis, and blood vessel leakage. DAAP can simultaneously bind VEGF-A and angiopoietins, blocking their actions. We believe that DAAP is a highly effective molecule for regressing tumor angiogenesis and metastasis in implanted and spontaneous solid tumors. It can also effectively reduce ascites formation and vascular leakage in an ovarian carcinoma model. Thus, simultaneous blockade of VEGF-A and angiopoietins with DAAP is an effective therapeutic strategy for blocking tumor angiogenesis, metastasis, and vascular leakage. Recently, based on Korean medicine literatures, 'Dong-eui-bo-gam (ٳ>l